BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29017478)

  • 1. Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study.
    Tonelli R; Cocconcelli E; Lanini B; Romagnoli I; Florini F; Castaniere I; Andrisani D; Cerri S; Luppi F; Fantini R; Marchioni A; Beghè B; Gigliotti F; Clini EM
    BMC Pulm Med; 2017 Oct; 17(1):130. PubMed ID: 29017478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.
    Dowman LM; McDonald CF; Hill CJ; Lee AL; Barker K; Boote C; Glaspole I; Goh NSL; Southcott AM; Burge AT; Gillies R; Martin A; Holland AE
    Thorax; 2017 Jul; 72(7):610-619. PubMed ID: 28213592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary rehabilitation for interstitial lung disease.
    Dowman L; Hill CJ; May A; Holland AE
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD006322. PubMed ID: 34559419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the severity of interstitial lung disease affect the gains from pulmonary rehabilitation?
    Deniz S; Şahin H; Yalnız E
    Clin Respir J; 2018 Jun; 12(6):2141-2150. PubMed ID: 29498799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease.
    Holland AE; Hill CJ; Glaspole I; Goh N; McDonald CF
    Respir Med; 2012 Mar; 106(3):429-35. PubMed ID: 22182340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success.
    Brunetti G; Malovini A; Maniscalco M; Balestrino A; Carone M; Visca D; Capelli A; Vitacca M; Bellazzi R; Piaggi G; Fuschillo S; Aliani M; Spanevello A; Prince I; Paneroni M; Ambrosino N
    Respir Med; 2021; 185():106473. PubMed ID: 34038844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study.
    Ryerson CJ; Cayou C; Topp F; Hilling L; Camp PG; Wilcox PG; Khalil N; Collard HR; Garvey C
    Respir Med; 2014 Jan; 108(1):203-10. PubMed ID: 24332409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion.
    Berton DC; Silveira L; Da Costa CC; De Souza RM; Winter CD; Zimermann Teixeira PJ
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1607-14. PubMed ID: 23416765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Short- and Long-Term Impact of Pulmonary Rehabilitation in Subjects with Sarcoidosis: A Prospective Study and Review of the Literature.
    Guber E; Wand O; Epstein Shochet G; Romem A; Shitrit D
    Respiration; 2021; 100(5):423-431. PubMed ID: 33784708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD.
    de Torres JP; Pinto-Plata V; Ingenito E; Bagley P; Gray A; Berger R; Celli B
    Chest; 2002 Apr; 121(4):1092-8. PubMed ID: 11948037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do we need a practice incremental shuttle walk test for patients with interstitial lung disease referred for pulmonary rehabilitation?
    Johnson-Warrington V; Sewell L; Morgan M; Singh S
    Respirology; 2015 Apr; 20(3):434-8. PubMed ID: 25615527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.
    Foglio K; Bianchi L; Bruletti G; Porta R; Vitacca M; Balbi B; Ambrosino N
    Respir Med; 2007 Sep; 101(9):1961-70. PubMed ID: 17531455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using 6-Min Walk Distance Expressed as a Percentage of Reference to Evaluate the Effect of Pulmonary Rehabilitation in Elderly Patients With Interstitial Lung Disease.
    Igarashi A; Iwanami Y; Sugino K; Gocho K; Homma S; Ebihara S
    J Cardiopulm Rehabil Prev; 2018 Sep; 38(5):342-347. PubMed ID: 29485525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
    Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
    Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease.
    Holland AE; Hill CJ; Conron M; Munro P; McDonald CF
    Thorax; 2008 Jun; 63(6):549-54. PubMed ID: 18245143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does inspiratory muscle training provide additional benefits during pulmonary rehabilitation in people with interstitial lung disease? A randomized control trial.
    Zaki S; Moiz JA; Mujaddadi A; Ali MS; Talwar D
    Physiother Theory Pract; 2023 Mar; 39(3):518-528. PubMed ID: 35001815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary rehabilitation for interstitial lung disease.
    Dowman L; Hill CJ; Holland AE
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006322. PubMed ID: 25284270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).
    Ammous O; Feki W; Lotfi T; Khamis AM; Gosselink R; Rebai A; Kammoun S
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013778. PubMed ID: 36606682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.
    Serajeddini H; Rogliani P; Mura M
    Lung; 2018 Dec; 196(6):707-713. PubMed ID: 30151723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.